Searched for
GLENMARK COVID DRUG
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Glenmark concludes study on COVID drug FavipiravirResults showed no new safety signals or concerns with the use of Favipiravir, and already-known side effects like weakness, gastritis, diar...
- Interim data from study supports Favipiravir's safety, effectiveness: GlenmarkThe study, commenced in July 2020, aimed to evaluate safety and efficacy of favipiravir in mild to moderate COVID-19 patients.
- Study shows Favipiravir provides multiple benefits in COVID-19 treatment: GlenmarkThe Phase 3 study with Favipiravir, sold under the brand name FabiFlu, by the company was conducted in 150 patients, it added. Favipiravir ...
- Glenmark to launch higher strength of FabiFlu for mild and moderate symptoms of Covid-19The higher strength will improve compliance for patients by effectively reducing the number of tablets required per day, Glenmark said in a...
- Glenmark defends price of its COVID-19 drug favipiravir version after DCGI sends notice“Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,” th...
- Glenmark drops 5% as DCGI seeks clarity on Covid-19 drug, overpricing complaintsThe drug regulator also pulled up Glenmark over the pricing of the drug, after receiving a complaint from a member of Parliament.
- DCGI pulls up Glenmark for false claims, overpricing of coronavirus drug FabiFluDrug Controller General (India) VG Somani in a letter dated July 17 has asked for a clarification on the matter for taking necessary action.
- Drug firms get DGCI nod for Covid drug favipiravir despite inconclusive studyOn Tuesday, Hyderabad-based Biophore India Pharmaceuticals said it has received approval from the Drug Controller General of India (DGCI) t...
- Glenmark Pharma cuts price of COVID-19 drug by 27% to Rs 75 per tabletIn a regulatory filing Glenmark announced a price reduction of 27 per cent for FabiFlu. The new maximum retail price (MRP) is Rs 75 per tab...
- Favirpiravir yet to find favour with ICMRHowever, the experts were not convinced and decided not to put it in the revised treatment protocol,” a person aware of the matter told ET ...
- Glenmark launches COVID-19 drug after DCGI nod; MRP at Rs 103 per tabletThe company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer p...
- Favipiravir and Remdesivir get approval for treatment“Under an accelerated approval process at the Central Drugs Standard Control Organisation (CDSCO), the Subject Expert Committee (SEC) has r...
- Glenmark launches Favipiravir: Medics say 'no magic bullet' for COVID but will help amid rising cases"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...
- Glenmark Pharma surges 35%, sees biggest intraday rise in history on Covid-19 drug launchThe firm launched antiviral drug Favipiravir for the treatment of Covid-19 patients.
- Glenmark Pharma to study potential Covid-19 drug combinationThe study will look to enroll 158 hospitalized patients of moderate Covid-19 in India, the company added. Last month, Glenmark said it woul...
- Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patientsThe Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipi...
- Glenmark pharma starts clinical trial on antiviral Favipiravir for Covid-19 treatmentThe drug sold under brand name Avigan by Fujifilm Toyama Chemical has demonstrated activity against influenza viruses and has been approved...
Load More
